Up to 200 new jobs will be created in Galway with Integer Holdings Corporation, a leading medical device outsource manufacturer, constructing a manufacturing facility in Parkmore East.
It adds to Integer’s 15 global manufacturing sites and current presence in Ireland, which includes an R&D centre in Galway and manufacturing facilities in Galway, and New Ross.
The initial phase of the project will include construction of a 60,000 square feet facility on land purchased from IDA Ireland and involves significant investment.
Construction is anticipated to commence in 2022, with a completion target of late 2023. When finished all new regional research, development and manufacturing will be housed in this facility, with equipment investments continuing over the following two to three years. The company has obtained planning permission for a total of 147,000 square feet for future expansion when needed.
Tánaiste and Minister for Enterprise Trade & Employment Leo Varadkar said: “I’m really pleased to see Integer announce further investment in Galway, with the addition of a new medical device innovation and manufacturing facility.
“I understand that this expansion will result in 100-200 new roles in the coming years, creating excellent employment opportunities for people in the area. This collaboration between IDA Ireland and Integer is another example of the valuable work that IDA Ireland do to bring investment into the country. I wish the team every success with this expansion.”
'This is a significant investment by a leading medical devices company and demonstrates Integer’s continued commitment to Galway'
Integer’s presence in Ireland spans more than 25 years. The company currently employs approximately 1,300 people in Ireland, with 350 located in Galway. The addition of the new Galway facility is projected to add an estimated 100-200 engineering, administration and manufacturing jobs to Integer over the next several years, while the design and construction activities are expected to employ several hundred third-party contractors in the Galway region.
“This expansion further demonstrates Integer’s commitment to supporting our customers’ growth strategies,” says Payman Khales, president of Integer’s Cardio and Vascular business. “The new Galway facility will allow us to continue our investments in research and development in this important medical device hub.”
The significant manufacturing space in the same facility will allow a seamless transition of new products from development to manufacturing, which will further enable us to help our customers bring products to market faster – a strategic priority as we advance our vision to enhance the lives of patients around the world.”
IDA Ireland CEO Martin Shanahan has also welcomed the news. “This is an important strategic move for the company, positioning it to meet growing demand globally for its products,” he says.
“This is a significant investment by a leading medical devices company and demonstrates Integer’s continued commitment to Galway and the West Region. Integer is a valued employer in Ireland where it has access to a highly skilled and talented workforce. I’d like to wish the company continued success.”